EligibleTrials

Tracking Results of Ablations to Combat AF Registry Generation 2

Recruiting · NCT05111015 · Observational (researchers observe without assigning treatment) · Lead sponsor: AtriCure, Inc.

View the official record on ClinicalTrials.gov →
Atrial Fibrillation

Interventions studied

AtriCure Hybrid Totally Thoracoscopic Ablation ProceduresAtriCure LAA Exclusion ProceduresHybrid (Convergent) Ablation ProceduresOpen Concomitant Surgical Ablation Procedures

What this trial is about

The primary objective of the TRAC-AF Registry is to capture real-world safety and effectiveness data on AtriCure devices used to conduct open concomitant and/or hybrid ablation, and management of the LAA concomitant to a cardiac ablation.

Who can take part

Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)

Inclusion criteria

Exclusion criteria

Where it is running

29 locations listed across 18 US states.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.